I want to talk again about out-of-pocket costs to the individual consumer.

But, surely, you are not pushing back on the point in the Rand study, that a $10 increase in co-pay----

I do not see that as minor. I take it to be a good point.

I really appreciate your having this hearing.

Just because a drug is prescribed does not mean a drug is actually taken according to the terms of that prescription.

This is not just about the out-of-pocket costs of the drugs, and it is not just about what the government spends on the drugs initially.

We ought to be focused more on patient management and relate to individuals.

We have got to change that if we are going to have better outcomes at lower costs.

Of course, this is, in my view, one of the best parts about the Affordable Care Act--is to close the donut hole so that we get more people filling their prescriptions.

I think we actually need a lot more research.

I really think the evidence suggests that concentration is one of those factors and that when we see the largest financial institutions getting bigger and bigger, that it tells us that we are not clearly on the path to resolving…

Thank you for being here, Secretary Lew. I want to start by talking about a different Brown Amendment.